ANNUAL REPORT 2017 - viforpharma.com
Vifor Pharma Ltd. Annual Report 2017 3 172 02 2017 at a glance 03 Table of contents 04 Ee ivexcut maegsse 08 Highlighs t 10 Our vision, mission and strategy 14 Perorf manceoeervwi v 18 Key medium-term growth drivers and products 20 – aferect In®j ®/ect nFerj i 26 – Vifor Fresenius Medical Care Renal Pharma 30 – Veltassa® 32 – eivsect …
Download ANNUAL REPORT 2017 - viforpharma.com
Information
Domain:
Source:
Link to this page:
Documents from same domain
English short version ANNUAL REPORT 2017
www.viforpharma.com2 36 172 Vifor Pharma Ltd. Annual Report 2017 AT A GLANCE ANNUAL REPORT 2017 Guidance raised at half-year, continued good performance in H2 led to strong full-year results
Related documents
Bios of panelists for data science 050217 - Rutgers …
ijobs.rutgers.edudisorders.(He(published(these(findings(in(aco2firstauthor(manuscriptin(Neuron,which(combined(with(work(from(others(in(the(lab(reclassified(these(human(disorders.((Jigar
Fortune.com - Fortune 500: Full List 1-100 - Tom …
tomweston.netFortune.com - Fortune 500: Full List 1-100 http://www.fortune.com/fortune/subs/fortune500/top500/0,23613,,00.html 1 of 4 11/27/2005 3:58 PM · Try 3 Issues Free
Strategic Analysis of the Pharma Market, Future …
www.fgcasal.orgStrategic Analysis of the Pharma Market, Future Revenue Models and Key Players 2 “Personalised medicine is a laudable aim, but we are not anywhere near there yet…
PHARMA M&A REPORT 2018 - kurmannpartners.com
www.kurmannpartners.com6 YEAR 2017 IN REVIEW J& Shortly after Merck’s announcement, Pfizer informed that they are seeking a buyer for their consumer health business.
Pfizer Pipeline
www.pfizer.comPfizer Pipeline Snapshot 4 Pipeline represents progress of R&D programs as of January 31, 2017 Included are 62 NMEs, 26 additional indications, plus 8 biosimilars
TaiGenBiopharmaceuticals Holdings Ltd. F*太 …
www.taigenbiotech.comA Research-Driven and Product Focus Company. An approved product A high value pipeline A productive R&D platform. Restricted & Confidential. 3
English short version ANNUAL REPORT 2017
www.viforpharma.com4 36 Vifor Pharma Ltd. Annual Report 2017 ExECUTiVE MESSAGE 172 ExECUT iVE CHA iRMAN Dear Shareholder, It is with great pleasure that I deliver my message as Executive Chairman for the first time following the